Siu, Wai Yi <br/><br/>
Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.  [electronic resource] 

 -  Molecular cancer therapeutics  May 2004 
 - 621-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibiotics, Antineoplastic--pharmacology<br/>Ataxia Telangiectasia Mutated Proteins<br/>Caffeine--pharmacology<br/>Camptothecin--antagonists & inhibitors<br/>Cell Cycle--drug effects<br/>Cell Cycle Proteins--metabolism<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>DNA Damage--drug effects<br/>DNA-Binding Proteins<br/>Dose-Response Relationship, Drug<br/>Doxorubicin--antagonists & inhibitors<br/>Enzyme Inhibitors--pharmacology<br/>G1 Phase--drug effects<br/>G2 Phase--drug effects<br/>Genes, cdc--drug effects<br/>Guanine Nucleotide Exchange Factors--metabolism<br/>Humans<br/>Nuclear Proteins--metabolism<br/>Protein Serine-Threonine Kinases--deficiency<br/>S Phase--drug effects<br/>Topoisomerase I Inhibitors<br/>Topoisomerase II Inhibitors<br/>Tumor Suppressor Proteins